PTGS2 and metabolic dysfunction-associated steatohepatitis: Nevertheless, it should be underlined that, regarding the impact of COX-2 on the development of NASH, data are controversial, as other studies suggested that PGE2 suppresses fibrogenesis, and COX-2 overexpression in hepatocytes may protect against NASH development by attenuating steatosis and inflammation [26,27].